Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.

Auderset F, Ballester M, Mastelic-Gavillet B, Fontannaz P, Chabaud-Riou M, Reveneau N, Garinot M, Mistretta N, Liu Y, Lambert PH, Ochs M, Siegrist CA.

Front Immunol. 2019 Jul 3;10:1520. doi: 10.3389/fimmu.2019.01520. eCollection 2019.

2.

Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.

Kari L, Whitmire WM, Crane DD, Reveneau N, Carlson JH, Goheen MM, Peterson EM, Pal S, de la Maza LM, Caldwell HD.

J Immunol. 2009 Jun 15;182(12):8063-70. doi: 10.4049/jimmunol.0804375.

3.

Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations.

Kari L, Whitmire WM, Carlson JH, Crane DD, Reveneau N, Nelson DE, Mabey DC, Bailey RL, Holland MJ, McClarty G, Caldwell HD.

J Infect Dis. 2008 Feb 1;197(3):449-56. doi: 10.1086/525285.

PMID:
18199030
4.
5.

Role of adhesin release for mucosal colonization by a bacterial pathogen.

Coutte L, Alonso S, Reveneau N, Willery E, Quatannens B, Locht C, Jacob-Dubuisson F.

J Exp Med. 2003 Mar 17;197(6):735-42. Epub 2003 Mar 10.

6.
7.
8.

Tetanus toxin fragment C-specific priming by intranasal infection with recombinant Bordetella pertussis.

Reveneau N, Alonso S, Jacob-Dubuisson F, Mercenier A, Locht C.

Vaccine. 2001 Dec 12;20(5-6):926-33.

PMID:
11738759
9.

Molecular characterization of Bordetella bronchiseptica filamentous haemagglutinin and its secretion machinery.

Jacob-Dubuisson F, Kehoe B, Willery E, Reveneau N, Locht C, Relman DA.

Microbiology. 2000 May;146 ( Pt 5):1211-21.

PMID:
10832649

Supplemental Content

Loading ...
Support Center